Hongsheng Capital
VC Fund
Hongsheng Capital is a VC fund focused on Health Care and Medical. Hongsheng Capital focuses on equity investment in the healthcare industry.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 71%
Last updated:
For AI agents: llms.txt
Industries Hongsheng Capital invests in
Stages Hongsheng Capital invests in
Countries Hongsheng Capital invests in
Investment Focus
Industry
- Health Care 3 (43%)
- Medical 2 (29%)
- Hospital 2 (29%)
- Biotechnology 2 (29%)
- Biopharma 1 (14%)
Stage
- Angel 2 (29%)
- Series A 2 (29%)
- Seed 1 (14%)
- Series B 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Fuxing Jiaer
|
Fuxing Jiaer is committed to building an evidence-based pediatric nutritional intervention system. | Angel / Mar 31, 2026 | |
|
Noah Source Medical
|
Noah Source Medical is a cutting-edge technological business that specializes in producing high-end full-spectrum flow cytometers through independent research and development. | Angel / Mar 30, 2026 | |
Yili Pharmaceutical
|
Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development. | $14.5M / Seed / Mar 12, 2026 | |
Methuselah
|
Methuselah is a research and development manufacturer of medical nutritional food. | $15M / Series B / Aug 04, 2025 | |
Warrenville
|
Warrenville is a forward-thinking high-tech enterprise dedicated to advancing hospital intelligence and automation through cutting-edge technologies. With a focus on improving healthcare delivery, the company develops innovative solutions that streamline hospital operations, enhance patient care, and optimize resource management. | Series A / Jun 18, 2025 | |
Enokiko
|
Enokiko is a provider of synthetic biology platforms oriented to the study, creation, and manufacturing of environmentally friendly biological products. | $20.6M / Series A / Mar 03, 2025 | |
|
Methuselah
|
Methuselah is a research and development manufacturer of medical nutritional food. | $27.5M / Series B / Feb 19, 2025 |
Co-Investors
Highlight Capital
2 deals together
Bioclub
1 deal together
CICC Capital
1 deal together
Fengqiao Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Hongsheng Capital invest in?
Hongsheng Capital invests primarily in Health Care, Medical and Hospital startups, most often at Angel and Series A stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hongsheng Capital last invest?
The most recent investment recorded for Hongsheng Capital closed in Mar 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
